Global Recombinant Human EGF Market – Regional Analysis
On the basis of region, the global recombinant human EGF market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to hold dominant position in the global recombinant human EGF market over the forecast period, owing to rising incidence of diabetes. For instance, according to National Diabetes Statistics Report- 2020 by Centers of Disease Control and Prevention, around 34.2 million people in the U.S. have diabetes while 34.5% of the U.S population are prediabetic. This is expected to boost the market growth of recombinant human EGF market as the rhEGFs are widely used for the treatment of diabetic foot ulcers.
Figure 2: Global Recombinant Human EGF Market Value (US$ 3,987.7 Mn), by Region, 2021
Recombinant Human (EGF) Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients